11 Nov, 2026

Novartis’ experimental cardiovascular drug fails a pivotal study

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the firm and to efforts to target a common heart disease risk factor.  […]

2 mins read

The child dies after receiving new experimental gene therapy

The first child to receive a new experimental gene therapy for a rare neurological disorder died a few days after the dosage, said society sponsoring this trial on Wednesday. The company, Capsida Biotherapeutics, is part of a group of companies and laboratories in engineering of new viruses potentially capable of securely transporting genes deeply in […]

1 min read